Concert Genetics (fka NextGxDX)
Healthcare Software · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(615) 861-2634Website
www.concertgenetics.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Concert Genetics (fka NextGxDX)
Concert Genetics is a software and managed services company that promotes health by providing the digital infrastructure for reliable and efficient management of genetic testing and precision medicine. Concert's genetic testing management capabilities leverage a proprietary database of the U.S. clinical genetic testing market, market-leading expertise, and a technology platform that supports genetic test ordering, resulting, coding, coverage, and payment integrity.Explore more
Popular SearchesConcert GeneticsConcert Genetics IncNextgxdxConcert Genetics (fka NextGxDX)Concert Genetics canSIC Code 73,737NAICS Code 51,513Show moreConcert Genetics (fka NextGxDX) Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Concert Genetics (fka NextGxDX) your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Concert Genetics (fka NextGxDX) recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Concert Genetics (fka NextGxDX) has new funding data
Congratulate Masked Content for being promoted to Masked Content at Concert Genetics (fka NextGxDX)
Click to see if Concert Genetics (fka NextGxDX) had a recent Job posting/layoffs
Product Launch: Get notified when Concert Genetics (fka NextGxDX) launches new products
Concert Genetics (fka NextGxDX), which may be a good buyer, showed buying intent in Masked Content Topic
Check if Concert Genetics (fka NextGxDX) has recently received funding, and reach out quickly before it becomes old news!
Check out if Concert Genetics (fka NextGxDX) is spiking on competitors!
Recommended Actions
Find VP level buyers at Concert Genetics (fka NextGxDX)
Find 3 more new buyers
Compare Similar Companies to Concert Genetics (fka NextGxDX)
Compare insights from companies similar to Concert Genetics (fka NextGxDX), focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Concert Genetics (fka NextGxDX) is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Concert Genetics (fka NextGxDX) is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Concert Genetics (fka NextGxDX).
Concert Genetics (fka NextGxDX) financials insights
Gather financial insights about Concert Genetics (fka NextGxDX), including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Concert Genetics (fka NextGxDX) Tech Stack
A closer look at the technologies used by Concert Genetics (fka NextGxDX)
Most Recent Scoops
Funding
Concert Genetics, Inc. has received an SBA PPP loan for $350,000-1 million from Franklin Synergy Bank.
Left Company
Executive Move
Executive Moves, Left Company
Promotion
Executive Move
Nick Tazik has been promoted to the role of Vice President, Growth.
Executive Moves, Promotion, Personnel Moves
Promotion
Executive Move
Concert Genetics (fka NextGxDX) News & Media
Concert Genetics Launches Genetic Test Payment Accuracy Solution for Medicare and Medicare Advantage
NASHVILLE, Tenn., Aug. 26, 2021 /PRNewswire/ -- Concert Genetics has launched a genetic testing payment accuracy and compliance solution for Medicare and Medicare Advantage plans. The offering extends Concert's innovative solution for commercial plans, providing unparalleled test...Concert Genetics Unveils Comprehensive Genetic Test Identification System to Enable Automation in Precision Medicine
NASHVILLE, Tenn., June 24, 2021 /PRNewswire/ -- Concert Genetics has released its comprehensive genetic test identification system for use in the market, enabling a level of automation in test ordering, coverage, payment and clinical decision support never before possible, the company...Concert Genetics Earns Patent for Innovative Methods of Automating Genetic Test Coverage and Payment Accuracy
NASHVILLE, Tenn., June 9, 2021 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued Concert Genetics patent US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today. As the patent...GeneMatters and Concert Genetics Partner to Scale Tech-Enabled Clinical Genetics Services
MINNEAPOLIS and NASHVILLE, Tenn., March 31, 2021 /PRNewswire/ -- GeneMatters, a leading provider of telegenetics services and software, and Concert Genetics, a healthcare technology company providing the digital infrastructure for genetic testing management, today announced a partnership...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Concert Genetics (fka NextGxDX)
Sign Up For FreeTo access detailed company insights
Concert Genetics is a software and managed services company that promotes health by providing the digital infrastructure for reliable and efficient management of genetic testing and precision medicine. Concert's genetic testing management capabilities leverage a proprietary database of the U.S. clinical genetic testing market, market-leading expert... Read More
